AMRX
AMRX
NASDAQ · Pharmaceuticals

Amneal Pharmaceuticals Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$18.71
+0.43 (+2.35%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +517.5% upside
Low Target $65.43
Average Target $115.54
High Target $156.42
Current Price $18.71
Current
$18.71
Target
$115.54
$65.43 $115.54 avg $156.42
Scenario Analysis
Bear Case
$65.43
249.7%
Low target
Base Case
$115.54
+517.5%
Avg target
Bull Case
$156.42
+736.0%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$19.26
-2.9% from high
52-Week Low
$9.49
+97.2% from low
50-Day SMA
$13.39
+39.7% vs SMA
200-Day SMA
$10.30
+81.7% vs SMA
RSI (14)
57.4
Neutral
Target vs 52W High
$115.54
+499.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +14.0%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +10.5%
MRK
Merck & Co. Inc.
 Buy 36 72% $159.27 +6.1%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +21.5%
BMY
Bristol-Myers Squibb Co
 Hold 35 43% $174.50 +177.1%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -37.9%
ZTS
Zoetis Inc
 Hold 24 50% $209.87 +193.9%